Page last updated: 2024-10-26

famotidine and Duodenal Diseases

famotidine has been researched along with Duodenal Diseases in 4 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Duodenal Diseases: Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).

Research Excerpts

ExcerptRelevanceReference
" Our purpose was to evaluate the occurrence of mycotic infection in patients with duodenal ulcer on anti-ulcer therapy and to compare the effects of cimetidine, famotidine, and omeprazole."9.08Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. ( Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P, 1996)
" Our purpose was to evaluate the occurrence of mycotic infection in patients with duodenal ulcer on anti-ulcer therapy and to compare the effects of cimetidine, famotidine, and omeprazole."5.08Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. ( Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goenka, MK1
Kochhar, R1
Chakrabarti, A1
Kumar, A1
Gupta, O1
Talwar, P1
Mehta, SK1
Wu, CS1
Lin, CJ1
Chen, TC1
Chen, PC1
Chiu, CC1
Miehsler, W1
Püspök, A1
Oberhuber, T1
Vogelsang, H1
Aabakken, L1
Bjørnbeth, BA1
Weberg, R1
Viksmoen, L1
Larsen, S1
Osnes, M1

Trials

2 trials available for famotidine and Duodenal Diseases

ArticleYear
Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
    Journal of clinical gastroenterology, 1996, Volume: 23, Issue:1

    Topics: Adult; Anti-Ulcer Agents; Candidiasis; Cimetidine; Duodenal Diseases; Duodenal Ulcer; Famotidine; Fe

1996
NSAID-associated gastroduodenal damage: does famotidine protection extend into the mid- and distal duodenum?
    Alimentary pharmacology & therapeutics, 1990, Volume: 4, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromium Radioisotopes; Double-Blind Method; Duodena

1990

Other Studies

2 other studies available for famotidine and Duodenal Diseases

ArticleYear
Ménétrier's disease: a new variant with duodenal involvement.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:6

    Topics: Aged; Barium Sulfate; Contrast Media; Duodenal Diseases; Famotidine; Gastric Fundus; Gastric Mucosa;

1997
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
    Inflammatory bowel diseases, 2001, Volume: 7, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio

2001